top of page
Welcome to M&AI, where innovation meets collaboration
Philippe Gillet
President
Philippe Gillet, renowned geophysicist, former director of ENS Lyon and VP of EPFL, expert in innovation and scientific strategy. A key asset to our team!
Jean-Marc Combette
Chief Operating Officer
Drug Development Strategist & Business Angel; Chairman of the Board at Buffavent Holding SA; CEO Solid Drug Development SA, brings 20+ years of experience in biotech and high-tech product development
Théodore Tillement
CEO & Food Resp.
Théodore Tillement, CEO and co-founder of M&WINE, leverages patented mineral profiling and AI to authenticate products, combat counterfeiting, and enhance traceability.
Amir Banifatemi
Chief AI Officer
Amir Banifatemi, business strategist with 25+ years in AI and tech, former Chief Innovation Officer at XPRIZE, and HEC Paris graduate.
Arthur Durand
Head of Chemistry
Talented chemist, specializes in developing innovativemetal toxicity treatments. As Head of Chemistry at M&AI, he brings exceptional expertise to drive innovation in material science and healthcare solutions.
Olivier Tillement
Chief Strategy Officer
Olivier Tillement, professor at Lyon 1 and entrepreneur, co-founded six startups, including NH TherAguix, advancing nanomedicine and cancer therapy.
Jules Tillement
Engineering Resp.
PhD in material science, brings expertise in imaging and photonics. His innovative mindset makes him a strong asset for M&AI’s AI and web development team.
Augustin Tillement
Health Resp.
Augustin Tillement, PhD and AI scientist, specializes in nanomaterial development. At M&AI, he leverages his expertise in AI and data-driven analysis to advance cutting-edge solutions.
Want to learn more about how M&AI can help your organization?
M&AI - Institut des Sciences Analytiques
25 rue Léon Fabre
69100, Villeurbanne, France
+33 (0)6 15 36 40 56
Théodore Tillement, CEO
bottom of page